Lycia Therapeutics Funding & Investors
South San Francisco, CA
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.
lyciatx.comTotal Amount Raised: $226,600,000
Lycia Therapeutics Funding Rounds
Series C
$106,600,000
Series C Investors
Venrock Healthcare Capital PartnersHenderson Global InvestorsCowenEli Lilly and CompanyRTW InvestmentsFranklin Resources, Inc.Marshall WaceInvusAlexandria Venture InvestmentsRedmile GroupBlue OwlSeries B
$70,000,000
Series B Investors
Redmile GroupCowenAlexandria Venture InvestmentsVersant VenturesInvusEli Lilly and CompanyRTW InvestmentsSeries A
$50,000,000
Series A Investors
Versant Ventures
Funding info provided by Diffbot.